Medea Inc.

Livermore, CA Doing business as Medea Medical Products

UEI
MKDBJ94R2X65
CAGE
8JQA1
Primary NAICS
424210 Drugs and Druggists' Sundries Merchant Wholesalers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
302 Lindbergh Ave, Livermore, CA 94551, USA
Website
medeausa.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $12,600

Contract awards

Award Agency Obligated Awarded
450 boxes of naloxone 9594CS25P0002 CSOSA $12,600
Covid-19 antigen OTC test kits -ihealth & acon W58P0522C0005 ACC Aberdeen Proving Ground $62,406,603
Medea PPE 70FA2020F00000025 FEMA Preparedness Section $43,681,249

Similar vendors

About the company

Medea Inc., doing business as Medea Medical Products, is a for-profit corporate entity registered in SAM.gov since March 2020, with a base of operations in Pleasanton, California. The company specializes in healthcare solutions and medical product distribution, focusing on providing critical medical supplies to federal agencies. As a small business contractor, Medea Inc. has established itself as a key supplier of personal protective equipment (PPE), medical testing kits, and emergency medical supplies during the COVID-19 pandemic and ongoing public health response efforts.

The company has secured significant federal contract awards from multiple agencies, primarily focused on pandemic-related medical supplies. Notable contracts include a $62.4 million award from the Department of the Army for COVID-19 antigen over-the-counter test kits (iHealth and Acon brands), a $43.7 million contract with FEMA for personal protective equipment, and a recent $12,600 contract with the Court Services and Offender Supervision Agency (CSOSA) for Naloxone nasal spray packages. These contracts were predominantly not set aside, indicating Medea Inc.'s competitive positioning in the federal marketplace. The company has demonstrated capability in rapidly supplying critical medical products during national emergencies, with performance locations primarily in Pleasanton, California.

Medea Inc. holds a significant indefinite delivery contract (IDV) from the Federal Emergency Management Agency with a potential ceiling value of $97.6 million, awarded in April 2020. This single-award contract was specifically designed to support COVID-19 pandemic response efforts by replenishing the Strategic National Stockpile with essential PPE and medical supplies. The IDV allowed FEMA to issue subsequent delivery orders, including the $43.7 million firm fixed-price order for PPE from May to September 2020. The contract was part of the National Interest Action for Coronavirus COVID-19, highlighting Medea Inc.'s critical role in supporting federal emergency preparedness and response infrastructure during the pandemic.

Quick answers

Is Medea Inc. registered in SAM.gov?

Yes. Medea Inc.'s SAM.gov registration is active through October 24, 2027.

What is Medea Inc.'s CAGE code?

Medea Inc.'s CAGE code is 8JQA1, and its Unique Entity ID (UEI) is MKDBJ94R2X65.

How much has Medea Inc. received in federal contracts?

Federal contracts obligated $12,600 to Medea Inc. in fiscal year 2025.

What is Medea Inc.'s most recent federal award?

Medea Inc.'s most recent federal contract award is 450 boxes of naloxone (9594CS25P0002), from CSOSA, on February 28, 2025.

On GovTribe

See Medea Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe